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WE examined the compartmentalization of bioactive tu-
mour necrosis factor (TNF) and interleukin 6 (IL-6) to the
subarachnoid space and systemic circulation in patients
with meningococcal meningitis and septic shock/bacter-
aemia. In patients with meningitis, median levels ofTNF
in 31 paired samples of cerebrospinal fluid (CSF) and
serum were respectively 783 pg/ml and below detection
limit (p < 0.001) and median levels of IL-6 were 150 ng/ml
and 0.3 ng/ml (p < 0.0001). In patients with septic shock
without meningitis, median levels in paired samples of
CSF and serum were respectively below detection limit
and 65 pg/ml (not significant, (ns)) (TNF, eleven patients)
and 1.3 ng/ml-3 ng/ml (ns) (IL-6, nine patients). The data
show that TNF and IL-6 are localized to the subarachnoid
space in patients with meningitis although the blood--
brain barrier is penetrable to serum proteins. On the other
hand, patients with septic shock tend to have cytokines in
both serum and CSF.
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Introduction
The blood-brain barrier is poorly penetrable to
most water soluble substances except for a few
nutrients and ions. The barrier thus separates the
subarachnoid space and the systemic circulation in
two anatomically and functionally different com-
partments. However, during an inflammatory
response the impenetrable character of the blood-
brain barrier may be modified as evidenced by
leakage of proteins from blood to CSF in
meningitis.
2 The transport across the inflamed
meninges is passive and directed by concentration
gradients. In addition, hydrostatic forces favour
transport from the circulation to the subarachnoid
space. Although there is evidence for compartmen-
talization of the initial production of cytokines,
little is known about how the altered permeability
of the blood-brain barrier influences the distribu-
tion of cytokines in the organism.
The dominant clinical manifestations of menin-
gococcal disease are meningitis and septic shock
and the authors have previously studied the
cytokine cascades separately in CSF and serum in
this disease. 3’4 The dual presentation of the disease
also provides an opportunity to study the function
of the blood-brain barrier and the degree of
compartmentalization of cytokines. In the present
study this question is addressed by comparing the
levels of TNF and IL-6 in paired samples of CSF
and serum from the same patients. The results show
that biologically active TNF and IL-6 are
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compartmentalized to the subarachnoid space in
patients with meningitis, whereas the cytokines
tend to be present in both compartments in patients
with septic shock/bacteraemia.
Patients and Methods
Patients: Characteristics of the patients and criteria
of the diagnosis are described previously. 3’4
Samples were obtained from 32 male and 28
female patients. The age range was 2-93 years,
63% of the patients were 10-20 years of age. The
patients had these manifestations: meningitis or
meningitis and bacteraemia (n 33), septic shock
(n 9), septic shock and meningitis (n 11), and
bacteraemia without meningitis or shock (n 7).
The patients were grouped in two categories,
patients with meningitis, and patients with septic
shock or bacteraemia. Patients with the combina-
tions meningitis/septic shock or meningitis/bacter-
aemia were included in the first group as these
patients have similar clinical courses and similar
systemic concentrations of endotoxin. Blood and
CSF were drawn on admission prior to treatment
with antibiotics. The samples were centrifuged, and
frozen at 70C.
Assays for TNF, IL-1 and IL-6: TNF levels were
determined by the cytotoxic effect of TNF on the
mouse fibrosarcoma cell line WEHI 164 clone 13
as described previously. IL-6 was determined by
the IL-6 dependent mouse hybridoma cell line B
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13.29 clone 9 (kindly provided by Dr Aarden,
University ofAmsterdam) as described previously.
Statistics: Differences between cytokine levels in
paired samples were tested for significance with
paired Wilcoxon rank sum test. p-values <0.05 in
two-sided tests were considered to be significant.
Results
Paired samples of CSF and serum were obtained
from 31 patients with meningitis (Fig. 1A).
Fourteen patients had no detectable TNF levels in
either CSF or serum. In all positive samples, TNF
was markedly higher in CSF (range 0-31070 pg/ml,
median 783 pg/ml) than in serum (range 0-214
pg/ml, median 0), p < 0.001. Similarly, paired
samples were obtained from eleven patients with
bacteraemia/septic shock (Fig. 1B). In seven of
these patients, TNF was higher in serum than in
CSF, whereas two patients had higher levels in CSF
than in serum (CSF, range 0-168 pg/ml, median 0.
Serum, range 0-35712 pg/ml, median 65 pg/ml, ns
difference).
IL-6: IL-6 is detected in a high proportion
(86-100%) of both the CSF and serum samples. 3’4
Figure 2A demonstrates that 26 of 29 patients with
meningitis from whom we obtained paired samples,
had higher levels of IL-6 in CSF than in serum
(CSF, range 0-859ng/ml, median 150ng/ml.
Serum, range 0-164 ng/ml, median 0.3 ng/ml,
p < 0.0001). In nine patients with septic shock/bac-
teraemia there was no significant difference between
the IL-6 levels in the two compartments (CSF,
range 0.1-807 ng/ml, median 1.3 ng/ml. Serum,
range 0-2400ng/ml, median 3 ng/ml, ns) (Fig.
2B).
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FIG. (A) TNF levels in CSF and serum from 31 patients with meningitis.
Each line denotes one patient, except the lowest one which denotes 14
patients with no detectable levels of TNF. (B) TNF levels in CSF and
serum from eleven patients with septic shock/bacteraemia. The lowest
denotes two patients with no detectable levels of TNF. Horizontal line
indicates detection limit of the assay.
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FIG. 2 (A) IL-6 levels in CSF and serum from 29 patients with meningitis.
Each line denotes one patient. (B) IL-6 levels in CSF and serum from
nine patients with septic shock/bacteraemia. Horizontal line indicates
detection limit of the assay.
Protein levels in CSF: The protein concentration in
CSF was analyzed because it reflects breakdown of
the blood-brain barrier and the degree of
communication between the subarachnoid space
and systemic circulation. Patients with meningitis
had median concentration of 3.7 g/1 (range
0.2-13.5 g/ml) whereas patients with septic shock
had 0.42 g/1 (0.23-5.4 g/l), (p < 0.5). The data are
in accordance with the current concept that serum
proteins leak across the blood-brain barrier in
meningitis.
Discussion
The present study demonstrates that bioactive
TNF and IL-6 are compartmentalized to the
subarachnoid space in patients with meningococcal
meningitis, whereas patients with septic shock have
cytokines both in serum and CSF.
In patients with meningitis the blood-brain
barrier becomes penetrable, as confirmed by
elevated protein levels in CSF in meningitis patients
in the present study. Others have suggested that
TNF may leak from CSF to serum during
meningitis. However, in spite of the marked
leakage of protein, and the high concentration
gradient ofTNF across the blood-brain barrier, the
authors’ data demonstrate that negligible amounts
of bioactive TNF leak from CSF to serum during
meningitis. By leakage from the subarachnoid space
to the systemic circulation there is a dilution factor
of 10-20. In addition, the cytokines may adhere to
tissue and cells in the systemic circulation, and,
furthermore, they may be inactivated by inhibitors
and soluble receptors in serum. Apparently, these
mechanisms are sufficient to minimize the effect of
leakage of cytokines during meningitis.
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In contrast, patients with septic shock/bacter-
aemia had a different pattern of cytokine presence
TNF and IL-6 were present in both serum and CSF
and the ranges of concentrations overlapped.
Apparently, there is no strict compartmentalization
of bioactive TNF and IL-6 during septic
shock/bacteraemia. A previous study has demon-
strated that 50% of the patients with septic shock
also have Neisseria meningitidis in CSF without
elevated leukocyte counts. The most reasonable
interpretation of these observations is that bacteria
are present and evoke a cytokine response also in
the subarachnoid space in septic shock patients,
although the host response does not include a
classical inflammatory reaction with elevated
leukocyte counts at the time of sampling.
An alternative interpretation that cytokines leak
across the blood-brain barrier is not likely because
a comparison between serum proteins in serum and
CSF indicate negligible leakage. From a pathophy-
siological point of view compartmentalization of
cytokines may help to localize the inflammatory
reaction during meningitis.
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